Experts say any short-term financial benefit will be outweighed by long-term health costs related to obesity
Faced with high demand for GLP-1 drugs, some American cities and states that previously covered the cost of the weight-loss medication for low-income residents and public employees have now started to restrict or eliminate coverage.
The pullback stem... [6225 chars]